University of Nottingham

Rio Tinto to develop BioIron™ R&D facility in Western Australia to test low-carbon steelmaking

Retrieved on: 
Dienstag, Juni 4, 2024
Natural Resources, Manufacturing, Other Manufacturing, Steel, Mining, Minerals, Biomass, Carbon, Rio Tinto, Hydrogen, University, University of Nottingham, High conservation value forest, Electricity, Tinto, Research, Coal, Iron, Metso, Iron ore

Rio Tinto will invest US$143 million (A$215 million) to develop a research and development facility in Western Australia to further assess the effectiveness of its low-carbon ironmaking process, BioIronTM, to support decarbonising the global steel value chain.

Key Points: 
  • Rio Tinto will invest US$143 million (A$215 million) to develop a research and development facility in Western Australia to further assess the effectiveness of its low-carbon ironmaking process, BioIronTM, to support decarbonising the global steel value chain.
  • BioIron uses raw biomass and microwave energy instead of coal to convert Pilbara iron ore to metallic iron in the steelmaking process.
  • The BioIron facility will include a pilot plant that will be ten times bigger than its predecessor in Germany.
  • Through discussions with environmental groups, as a first step Rio Tinto has ruled out sources that support the logging of old growth and High Conservation Value forests.

Atrogi Announces Publication on Advancements in Combatting Obesity and Metabolic Complications

Retrieved on: 
Freitag, Mai 24, 2024
Physiology, Metabolism, Stockholm University, University of Queensland, DSM-IV codes, Facial muscles, Karolinska Institute, Camp, Obesity, Adipose tissue, Monash University, University, Steatohepatitis, IND, Disease, Drug development, Health, Organic Syntheses, University of Copenhagen, University of Nottingham, Research, CSO, Body composition, Journal, Weight loss, Queensland University of Technology, Pharmaceutical industry

STOCKHOLM, Sweden, May 24, 2024 (GLOBE NEWSWIRE) -- Atrogi, a pioneering clinical-stage biotech company advancing treatments for metabolic disorders, announces a publication in the Journal of Molecular Metabolism (1).

Key Points: 
  • STOCKHOLM, Sweden, May 24, 2024 (GLOBE NEWSWIRE) -- Atrogi, a pioneering clinical-stage biotech company advancing treatments for metabolic disorders, announces a publication in the Journal of Molecular Metabolism (1).
  • The research paper validates the mechanism of action of the company’s first-in-class, small molecule, ATR-127, in combating obesity and metabolic complications.
  • Unlike existing anti-obesity therapies that compromise lean muscle mass, ATR-127 induces significant weight loss while preserving crucial lean body mass.
  • ATR-127 binds to both the beta-2 and beta-3 adrenergic receptors in a unique manner, allowing for precise modulation of downstream signaling cascades.

The Renowned Port City of Ningbo Reopened the Window for International Exchanges with Unveiled Ningbo International Communication Center

Retrieved on: 
Freitag, Mai 10, 2024
UNESCO, Rural area, University, Civilization, Collection, Book, Archive, Young, University of Nottingham, Research, Gene, Provost, Georgios Papandreou, Culture, Teaching, Boao Forum for Asia, Tourism

NINGBO, China, May 10, 2024 /PRNewswire/ -- Ningbo, a famous port city in China, has added a window for foreign exchanges.

Key Points: 
  • NINGBO, China, May 10, 2024 /PRNewswire/ -- Ningbo, a famous port city in China, has added a window for foreign exchanges.
  • Ningbo International Communication Center was unveiled on May 8, 2024.
  • As a famous port city, Ningbo Zhoushan Port has ranked first in the world in cargo throughput for 15 consecutive years.
  • The newly unveiled Ningbo International Communication Center will focus on "NB-PLUS", serve foreign exchanges, cultivate foreign exchange industries, and promote the integration of industrial chains, innovation chains, and production chains.

The Renowned Port City of Ningbo Reopened the Window for International Exchanges with Unveiled Ningbo International Communication Center

Retrieved on: 
Freitag, Mai 10, 2024
UNESCO, Rural area, University, Civilization, Collection, Book, Archive, Young, University of Nottingham, Research, Gene, Provost, Georgios Papandreou, Culture, Teaching, Boao Forum for Asia, Tourism

NINGBO, China, May 10, 2024 /PRNewswire/ -- Ningbo, a famous port city in China, has added a window for foreign exchanges.

Key Points: 
  • NINGBO, China, May 10, 2024 /PRNewswire/ -- Ningbo, a famous port city in China, has added a window for foreign exchanges.
  • Ningbo International Communication Center was unveiled on May 8, 2024.
  • As a famous port city, Ningbo Zhoushan Port has ranked first in the world in cargo throughput for 15 consecutive years.
  • The newly unveiled Ningbo International Communication Center will focus on "NB-PLUS", serve foreign exchanges, cultivate foreign exchange industries, and promote the integration of industrial chains, innovation chains, and production chains.

HungryPanda Honours Top Chinese Restaurants in the UK at Global Golden Panda Award Gala

Retrieved on: 
Montag, März 18, 2024
Growth, MP, Digital, U35, University, Food, University of Nottingham, Language, Jinli, Tourism

LONDON, March 18, 2024 /PRNewswire/ -- HungryPanda , the world's leading overseas Asian food delivery platform hosted the 2023 Golden Panda Award Gala on Friday March 1 at the Pan Pacific Hotel in London, UK.

Key Points: 
  • LONDON, March 18, 2024 /PRNewswire/ -- HungryPanda , the world's leading overseas Asian food delivery platform hosted the 2023 Golden Panda Award Gala on Friday March 1 at the Pan Pacific Hotel in London, UK.
  • The 'Golden Panda Award' is a symbol of excellence in the global overseas Chinese food industry, setting the highest standard for culinary achievement.
  • "Our commitment to promoting and celebrating outstanding achievements in international Asian cuisine is embodied by the 'Golden Panda Award'," said Kelu Liu, CEO of HungryPanda.
  • This year, 247 HungryPanda merchants worldwide received the esteemed Golden Panda Award honour, 43 of which are located in the UK.

Vivani Medical Appoints Daniel Bradbury to its Board of Directors

Retrieved on: 
Mittwoch, März 6, 2024
Biotechnology, Pharmaceutical, Health, Acquisition, Medicine, Illumina, Inc., Obesity, Marketing, Amylin Pharmaceuticals, Audit committee, University, University of Nottingham, Therapy, Management, DSM-IV codes, Bristol Myers Squibb, Vivani, Pharmaceutical industry

Vivani Medical, Inc. (Nasdaq: VANI ) (“Vivani” or the “Company”), an innovative, preclinical-stage biopharmaceutical company developing novel, long-term drug implants, today announced the appointment of long-time industry veteran Daniel Bradbury to its Board of Directors.

Key Points: 
  • Vivani Medical, Inc. (Nasdaq: VANI ) (“Vivani” or the “Company”), an innovative, preclinical-stage biopharmaceutical company developing novel, long-term drug implants, today announced the appointment of long-time industry veteran Daniel Bradbury to its Board of Directors.
  • Bradbury serves on the board of directors of Castle Biosciences, Inc. and Equillium, Inc., and several private companies and philanthropic organizations.
  • Bradbury previously served on the board of directors of Biocon Limited, Corcept Therapeutics Inc., Geron Inc., Illumina Inc. and Intercept Pharmaceuticals Inc.
  • In addition to his new role as Board Director, Bradbury will serve on the Audit Committee of the Vivani Medical Board.

PomeGran Appoints New CEO and CFO to Execute Strategic Scaling Initiatives as Canada’s Leading Fibre-centric Rural Broadband Provider Expands

Retrieved on: 
Donnerstag, Februar 22, 2024
Networks, Mobile, Wireless, Other Technology, Technology, Telecommunications, CFO, Com, Western University, Growth, Rogers Wireless, MBA, Princeton University, Stanford University, University of Nottingham, Engineering, Business, Xplore, Apple, Digital divide, Management

PomeGran Inc. , Canada’s leading fibre-centric rural broadband provider, announced today the appointment of two telecom veterans to the C-suite, to add executive leadership strength and increase the company’s focus on strategic scaling initiatives for its hyper-expansion across rural Canada and the US.

Key Points: 
  • PomeGran Inc. , Canada’s leading fibre-centric rural broadband provider, announced today the appointment of two telecom veterans to the C-suite, to add executive leadership strength and increase the company’s focus on strategic scaling initiatives for its hyper-expansion across rural Canada and the US.
  • PomeGran has appointed Brent Johnston as CEO and Kurban Khanbhai as CFO, both effective immediately.
  • Johnston is a seasoned telecom executive, with his most recent tenure as President of Rogers Wireless.
  • Over the next six months, Brent and Kurban will be supporting PomeGran’s expansion strategies, including additional acquisitions and broadband network expansion projects.

NIO Inc. Announces Board Change

Retrieved on: 
Mittwoch, Februar 7, 2024
American University, Science, Henley Business School, Engineering, Data infrastructure, Ford Motor Company, American University of Beirut, Boston University, MBA, Jaguar Land Rover, Investment, Communication, University of Nottingham, Information, University, NIO

SHANGHAI, China, Feb. 07, 2024 (GLOBE NEWSWIRE) -- (NYSE: NIO; HKEX: 9866; SGX: NIO) (“NIO” or the “Company”), a pioneer and a leading company in the premium smart electric vehicle market, today announced that Mr. Eddy Georges Skaf and Mr. Nicholas Paul Collins have been appointed as new directors by the Company’s board of directors (the “Board”), with effect from February 7, 2024.

Key Points: 
  • SHANGHAI, China, Feb. 07, 2024 (GLOBE NEWSWIRE) -- (NYSE: NIO; HKEX: 9866; SGX: NIO) (“NIO” or the “Company”), a pioneer and a leading company in the premium smart electric vehicle market, today announced that Mr. Eddy Georges Skaf and Mr. Nicholas Paul Collins have been appointed as new directors by the Company’s board of directors (the “Board”), with effect from February 7, 2024.
  • Mr. Eddy Georges Skaf has held the position of chief investment officer at CYVN Holdings L.L.C since May 2023.
  • Previously, from August 2019 to May 2023, Mr. Skaf served as a senior advisor to Digital Infrastructure at Mubadala.
  • The Company would like to welcome Mr. Eddy Georges Skaf and Mr. Nicholas Paul Collins to the Board.

EnteroBiotix Strengthens its Executive Team, Appoints COO and CFO

Retrieved on: 
Donnerstag, Februar 1, 2024
Bachelor of Science, Growth, CFO, Therapy, Patient, KPMG, Vertex Pharmaceuticals, Regulatory affairs, Biomedical sciences, Urinary tract infection, Physics, University of Nottingham, University, Doctor of Philosophy, Senior, Clinical research

Dr Barnes has eighteen years’ early and late phase drug development and business operations leadership experience, spanning several therapeutic areas.

Key Points: 
  • Dr Barnes has eighteen years’ early and late phase drug development and business operations leadership experience, spanning several therapeutic areas.
  • He joins the Company from BerGenBio, a biotech company developing innovative drugs for oncology and serious respiratory infections, where he was COO.
  • Dr Barnes previously worked at Vertex Pharmaceuticals as Director of Regulatory Affairs where he led the strategy development of several breakthrough products.
  • With our first clinical data expected this year, the newly strengthened Executive Team will support the development and growth of our business.

A Powerful Alliance: Dexcom G7 Now Connects to Tandem t:slim X2

Retrieved on: 
Montag, Januar 15, 2024
Wearables, Mobile Technology, Technology, Medical Devices, Diabetes, Clinical Trials, Health Technology, Software, Biotechnology, Health, Data Management, CGM, FIN Atlantic Film Festival, Dexcom, EASD, Associate professor, Partnership, Hypoglycemia, University, Risk, DXCM, Diabetic retinopathy, Insulin, G7, Tandem Diabetes Care, AID, Tandem, University of Nottingham, Medical device

DexCom, Inc. (Nasdaq: DXCM), a global leader in real-time continuous glucose monitoring for people with diabetes, announced today the Dexcom G7 Continuous Glucose Monitoring (CGM) System now connects with the t:slim X2™ insulin pump by Tandem Diabetes Care in countries across Europe and in South Africa.

Key Points: 
  • DexCom, Inc. (Nasdaq: DXCM), a global leader in real-time continuous glucose monitoring for people with diabetes, announced today the Dexcom G7 Continuous Glucose Monitoring (CGM) System now connects with the t:slim X2™ insulin pump by Tandem Diabetes Care in countries across Europe and in South Africa.
  • The announcement comes just a month after the system launched in the United States and combines the power and accuracy of Dexcom G7 with the discretion of the Tandem t:slim X2.
  • Additionally, the COMISAIR seven-year follow up demonstrated further substantial reduction in HbA1c when Dexcom CGM is connected to the t:slim X2 insulin pump with Control-IQ technology5.
  • To learn more and to get started with Dexcom G7 and the Tandem t:slim X2 insulin pump, visit Dexcom.co.uk/tandem.